Skip to main content
Top
Published in: Arthritis Research & Therapy 5/2013

Open Access 01-10-2013 | Research article

The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis

Authors: Raquel López-Mejías, Fernanda Genre, Mercedes García-Bermúdez, Alfonso Corrales, Carlos González-Juanatey, Javier Llorca, José A Miranda-Filloy, Javier Rueda-Gotor, Ricardo Blanco, Santos Castañeda, Javier Martín, Miguel A González-Gay

Published in: Arthritis Research & Therapy | Issue 5/2013

Login to get access

Abstract

Introduction

Rheumatoid arthritis (RA) is a complex polygenic disease associated with chronic inflammation, accelerated atherosclerosis and increased cardiovascular (CV) mortality. A recent meta-analysis has described the ZC3HC1 rs11556924 polymorphism as one of the most important signals associated with coronary artery disease (CAD) in non-rheumatic Caucasian individuals. In this study we evaluated the potential association of this gene polymorphism with subclinical atherosclerosis assessed by the evaluation of carotid intima-media thickness (cIMT) in RA patients.

Methods

This study included 502 RA patients from Northern Spain. The ZC3HC1 rs11556924 polymorphism was genotyped with TaqMan single-nucleotide polymorphism (SNP) genotyping assays (C__31283062_10) in a 7900HT real-time polymerase chain reaction (PCR) system. cIMT was also assessed in these patients by carotid ultrasonography (US) technology.

Results

RA patients carrying the TT genotype had significantly higher cIMT values than those homozygous for the CC genotype (mean ± standard deviation (SD): 0.76 ± 0.18 mm and mean ± SD: 0.71 ± 0.16 mm respectively; P = 0.03) even after adjusting the results for sex, age at the time of US study, follow-up time and traditional CV risk factors (P = 0.04) evidencing that the effect conferred by ZC3HC1 rs11556924 polymorphism is independent of the traditional CV risk factors.

Conclusion

Our results indicate that ZC3HC1 rs11556924 polymorphism is associated with subclinical atherosclerosis in RA.
Literature
1.
go back to reference Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J: Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum. 2005, 35: 8-17. 10.1016/j.semarthrit.2005.03.004.CrossRefPubMed Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J: Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum. 2005, 35: 8-17. 10.1016/j.semarthrit.2005.03.004.CrossRefPubMed
2.
go back to reference Chung CP, Oeser A, Raggi P, Gebretsadik T, Shintani AK, Sokka T, Pincus T, Avalos I, Stein CM: Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum. 2005, 52: 3045-3053. 10.1002/art.21288.CrossRefPubMed Chung CP, Oeser A, Raggi P, Gebretsadik T, Shintani AK, Sokka T, Pincus T, Avalos I, Stein CM: Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors. Arthritis Rheum. 2005, 52: 3045-3053. 10.1002/art.21288.CrossRefPubMed
3.
go back to reference Dessein PH, Norton GR, Woodiwiss AJ, Joffe BI, Wolfe F: Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol. 2007, 34: 943-951.PubMed Dessein PH, Norton GR, Woodiwiss AJ, Joffe BI, Wolfe F: Influence of nonclassical cardiovascular risk factors on the accuracy of predicting subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol. 2007, 34: 943-951.PubMed
4.
go back to reference Rodriguez-Rodriguez L, Lopez-Mejias R, Garcia-Bermudez M, Gonzalez-Juanatey C, Gonzalez-Gay MA, Martin J: Genetic markers of cardiovascular disease in rheumatoid arthritis. Mediators Inflamm. 2012, 2012: 574817-PubMedCentralPubMed Rodriguez-Rodriguez L, Lopez-Mejias R, Garcia-Bermudez M, Gonzalez-Juanatey C, Gonzalez-Gay MA, Martin J: Genetic markers of cardiovascular disease in rheumatoid arthritis. Mediators Inflamm. 2012, 2012: 574817-PubMedCentralPubMed
5.
go back to reference Gonzalez-Juanatey C, Llorca J, Testa A, Revuelta J, Garcia-Porrua C, Gonzalez-Gay MA: Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore). 2003, 82: 407-413. 10.1097/01.md.0000101572.76273.60.CrossRef Gonzalez-Juanatey C, Llorca J, Testa A, Revuelta J, Garcia-Porrua C, Gonzalez-Gay MA: Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore). 2003, 82: 407-413. 10.1097/01.md.0000101572.76273.60.CrossRef
6.
go back to reference Kerekes G, Soltesz P, Nurmohamed MT, Gonzalez-Gay MA, Turiel M, Vegh E, Shoenfeld Y, McInnes I, Szekanecz Z: Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nat Rev Rheumatol. 2012, 8: 224-234. 10.1038/nrrheum.2012.16.CrossRefPubMed Kerekes G, Soltesz P, Nurmohamed MT, Gonzalez-Gay MA, Turiel M, Vegh E, Shoenfeld Y, McInnes I, Szekanecz Z: Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nat Rev Rheumatol. 2012, 8: 224-234. 10.1038/nrrheum.2012.16.CrossRefPubMed
7.
go back to reference van Sijl AM, Peters MJ, Knol DK, de Vet HC, Gonzalez-Gay MA, Smulders YM, Dijkmans BA, Nurmohamed MT: Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. Semin Arthritis Rheum. 2011, 40: 389-397. 10.1016/j.semarthrit.2010.06.006.CrossRefPubMed van Sijl AM, Peters MJ, Knol DK, de Vet HC, Gonzalez-Gay MA, Smulders YM, Dijkmans BA, Nurmohamed MT: Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis. Semin Arthritis Rheum. 2011, 40: 389-397. 10.1016/j.semarthrit.2010.06.006.CrossRefPubMed
8.
go back to reference Gonzalez-Juanatey C, Llorca J, Martin J, Gonzalez-Gay MA: Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2009, 38: 366-371. 10.1016/j.semarthrit.2008.01.012.CrossRefPubMed Gonzalez-Juanatey C, Llorca J, Martin J, Gonzalez-Gay MA: Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum. 2009, 38: 366-371. 10.1016/j.semarthrit.2008.01.012.CrossRefPubMed
9.
go back to reference Schunkert H, Konig IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, Preuss M, Stewart AF, Barbalic M, Gieger C, Absher D, Aherrahrou Z, Allayee H, Altshuler D, Anand SS, Andersen K, Anderson JL, Ardissino D, Ball SG, Balmforth AJ, Barnes TA, Becker DM, Becker LC, Berger K, Bis JC, Boekholdt SM, Boerwinkle E, Braund PS, Brown MJ, Burnett MS: Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011, 43: 333-338. 10.1038/ng.784.PubMedCentralCrossRefPubMed Schunkert H, Konig IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, Preuss M, Stewart AF, Barbalic M, Gieger C, Absher D, Aherrahrou Z, Allayee H, Altshuler D, Anand SS, Andersen K, Anderson JL, Ardissino D, Ball SG, Balmforth AJ, Barnes TA, Becker DM, Becker LC, Berger K, Bis JC, Boekholdt SM, Boerwinkle E, Braund PS, Brown MJ, Burnett MS: Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011, 43: 333-338. 10.1038/ng.784.PubMedCentralCrossRefPubMed
10.
go back to reference Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002/art.1780310302.CrossRefPubMed Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988, 31: 315-324. 10.1002/art.1780310302.CrossRefPubMed
11.
go back to reference Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D: Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010, 2010: 1580-1588.CrossRef Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D: Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010, 2010: 1580-1588.CrossRef
12.
go back to reference Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Pineiro A, Garcia-Porrua C, Miranda-Filloy JA, Ollier WE, Martin J, Llorca J: HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum. 2007, 57: 125-132. 10.1002/art.22482.CrossRefPubMed Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Pineiro A, Garcia-Porrua C, Miranda-Filloy JA, Ollier WE, Martin J, Llorca J: HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum. 2007, 57: 125-132. 10.1002/art.22482.CrossRefPubMed
13.
go back to reference Corrales A, Gonzalez-Juanatey C, Peiro ME, Blanco R, Llorca J, Gonzalez-Gay MA: Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study. Ann Rheum Dis. in press Corrales A, Gonzalez-Juanatey C, Peiro ME, Blanco R, Llorca J, Gonzalez-Gay MA: Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study. Ann Rheum Dis. in press
14.
go back to reference Gonzalez-Juanatey C, Llorca J, Garcia-Porrua C, Martin J, Gonzalez-Gay MA: Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis. Arthritis Rheum. 2006, 55: 150-153. 10.1002/art.21707.CrossRefPubMed Gonzalez-Juanatey C, Llorca J, Garcia-Porrua C, Martin J, Gonzalez-Gay MA: Effect of anti-tumor necrosis factor alpha therapy on the progression of subclinical atherosclerosis in severe rheumatoid arthritis. Arthritis Rheum. 2006, 55: 150-153. 10.1002/art.21707.CrossRefPubMed
15.
go back to reference Naredo E, Moller I, Gutierrez M, Bong DA, Cobo T, Corominas H, Corrales A, Di Geso L, Garcia-Vivar ML, Iagnocco A, Macarrón P, Navio T, Garrido J, González-Juanatey C: Multi-examiner reliability of automated radio frequency-based ultrasound measurements of common carotid intima-media thickness in rheumatoid arthritis. Rheumatology (Oxford). 2011, 50: 1860-1864. 10.1093/rheumatology/ker206.CrossRef Naredo E, Moller I, Gutierrez M, Bong DA, Cobo T, Corominas H, Corrales A, Di Geso L, Garcia-Vivar ML, Iagnocco A, Macarrón P, Navio T, Garrido J, González-Juanatey C: Multi-examiner reliability of automated radio frequency-based ultrasound measurements of common carotid intima-media thickness in rheumatoid arthritis. Rheumatology (Oxford). 2011, 50: 1860-1864. 10.1093/rheumatology/ker206.CrossRef
16.
go back to reference López-Mejías R, González-Juanatey C, García-Bermúdez M, Castañeda S, Miranda-Filloy JA, Blanco R, Llorca J, Martín J, González-Gay MA: The lp13.3 genomic region -rs599839- is associated with endothelial dysfunction in patients with rheumatoid arthritis. Arthritis Res Ther. 2012, 14: R42-10.1186/ar3755.PubMedCentralCrossRefPubMed López-Mejías R, González-Juanatey C, García-Bermúdez M, Castañeda S, Miranda-Filloy JA, Blanco R, Llorca J, Martín J, González-Gay MA: The lp13.3 genomic region -rs599839- is associated with endothelial dysfunction in patients with rheumatoid arthritis. Arthritis Res Ther. 2012, 14: R42-10.1186/ar3755.PubMedCentralCrossRefPubMed
17.
go back to reference García-Bermúdez M, López-Mejías R, González-Juanatey C, Corrales A, Castañeda S, Miranda-Filloy JA, Gómez-Vaquero C, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, Blanco R, González-Álvaro I, Llorca J, Martín J, González-Gay MA: Association study of MIA3 rs17465637 polymorphism with cardiovascular disease in rheumatoid arthritis patients. DNA Cell Biol. 2012, 31: 1412-1417. 10.1089/dna.2012.1672.CrossRefPubMed García-Bermúdez M, López-Mejías R, González-Juanatey C, Corrales A, Castañeda S, Miranda-Filloy JA, Gómez-Vaquero C, Fernández-Gutiérrez B, Balsa A, Pascual-Salcedo D, Blanco R, González-Álvaro I, Llorca J, Martín J, González-Gay MA: Association study of MIA3 rs17465637 polymorphism with cardiovascular disease in rheumatoid arthritis patients. DNA Cell Biol. 2012, 31: 1412-1417. 10.1089/dna.2012.1672.CrossRefPubMed
18.
go back to reference Bassermann F, von Klitzing C, Münch S, Bai RY, Kawaguchi H, Morris SW, Peschel C, Duyster J: NIPA defines an SCF-type mammalian E3 ligase that regulates mitotic entry. Cell. 2005, 122: 45-57. 10.1016/j.cell.2005.04.034.CrossRefPubMed Bassermann F, von Klitzing C, Münch S, Bai RY, Kawaguchi H, Morris SW, Peschel C, Duyster J: NIPA defines an SCF-type mammalian E3 ligase that regulates mitotic entry. Cell. 2005, 122: 45-57. 10.1016/j.cell.2005.04.034.CrossRefPubMed
19.
go back to reference Li R, Morris S: W. Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy. Med Res Rev. 2008, 3: 372-412.CrossRef Li R, Morris S: W. Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy. Med Res Rev. 2008, 3: 372-412.CrossRef
20.
go back to reference López-Mejías R, Corrales A, Genre F, Hernández JL, Ochoa R, Blanco R, González-Juanatey C, Martín J, Llorca J, González-Gay MA: Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2013, 31: 761-766.PubMed López-Mejías R, Corrales A, Genre F, Hernández JL, Ochoa R, Blanco R, González-Juanatey C, Martín J, Llorca J, González-Gay MA: Angiopoietin-2 serum levels correlate with severity, early onset and cardiovascular disease in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2013, 31: 761-766.PubMed
Metadata
Title
The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis
Authors
Raquel López-Mejías
Fernanda Genre
Mercedes García-Bermúdez
Alfonso Corrales
Carlos González-Juanatey
Javier Llorca
José A Miranda-Filloy
Javier Rueda-Gotor
Ricardo Blanco
Santos Castañeda
Javier Martín
Miguel A González-Gay
Publication date
01-10-2013
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 5/2013
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar4335

Other articles of this Issue 5/2013

Arthritis Research & Therapy 5/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine